REGENLIFESCIENCES
LIVE

Serial Number

98717227

Owner

RegenLab USA, LLC

Attorney

LINDSAY H. KAPLAN

Filing Date

Aug 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

REGENLIFESCIENCES Trademark

Serial Number: 98717227

REGENLIFESCIENCES is a trademark filed by RegenLab USA, LLC on August 26, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

RegenLab USA, LLC

92 Greene Street
Jersey City, NJ 07302

Entity Type: 16

Trademark Details

Filing Date

August 26, 2024

Registration Date

Not Registered

Published for Opposition

August 12, 2025

Goods & Services

Publishing of journals, books and guides in the field of medicine; providing education services, namely, classes and training in the field of medicine; organization and conducting of colloquiums, symposiums, conferences, seminars, congresses and workshops in the field of business management, cellular and tissue regeneration, regenerative medicine, rejuvenation, and isolating, treating and injecting blood platelets or cells into patients; organization and conducting of educational and entertainment exhibitions and cultural events for cultural, educational, training or instructional purposes; providing of training in the field of marketing, business development, cellular and tissue regeneration, regenerative medicine, rejuvenation, and isolating, treating and injecting blood platelets or cells into patients; vocational training in the field of cellular and tissue regeneration, regenerative medicine, rejuvenation, and isolating, treating and injecting blood platelets or cells into patients; consultancy, advice, and training for business executives, health care workers, health care specialists, medical doctors and patients in the fields of cellular and tissue regeneration, regenerative medicine, rejuvenation, and isolating, treating and injecting blood platelets or cells into patients; educational services, namely, providing classes in the field of medicine, cellular and tissue regeneration, regenerative medicine, rejuvenation, and isolating, treating and injecting blood platelets or cells into patients; publication of newspapers; publication of magazines; publication of journals; publication of texts other than advertising or publicity texts; publishing books of developed photographs for others; providing information about education; publishing electronic books or publications; vocational guidance in the field of healthcare and medical, surgical, veterinary, cosmetic, hygienic and beauty care; online electronic publishing of periodicals; preparing online periodicals, namely, writing of articles for periodicals other than for advertising or publicity purposes; photography; providing on-line electronic publications, not downloadable, in the nature of periodicals and newsletters in the fields of cellular and tissue regeneration, regenerative medicine, rejuvenation, and isolating, treating and injecting blood platelets or cells into patients; organization of balls; organization of live show performances for entertainment purposes; presentation of live show performances; all of the above services rendered in the field of cellular and tissue regeneration, regenerative medicine, rejuvenation, and isolating, treating and injecting blood platelets or cells into patients

Providing online medical advice and information in the field of cellular and tissue regeneration, regenerative medicine, rejuvenation, and isolating, treating and injecting blood platelets or cells into patients; providing an online computer database in the field of medical advice and information in the field of cellular and tissue regeneration, regenerative medicine, rejuvenation, and isolating, treating and injecting blood platelets or cells into patients

Implantable 3D mesh comprised primarily of artificial materials; medical devices and apparatus, namely, surgical mesh graft made primarily of artificial materials; surgical implants and mesh made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; implants comprising natural, non-living material; medical apparatus and instruments, namely, surgical scissors for use in cosmetics, esthetics, facial, face-lift and plastic surgery; medical apparatus used for introducing pharmaceutical preparations into the human body

Implantable 3D mesh comprised primarily of living tissue; implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the treatment of soft tissue deficiencies; implants comprising living tissue; biological preparations for medical use, namely, thrombin, platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, hyaluronic acid, chitosan, silk or any combinations thereof, for the treatment of damaged skin or tissue; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; cells for medical or clinical purposes

Research and development in the field of pharmaceuticals and biotechnology; research services, namely, scientific research study in the field of tissue and cellular regeneration and rejuvenation, regenerative medicine, isolation and application of a patient's own platelets and cells; electronic storage services in the nature of database management, namely, electronic storage of business records of others

Filing History

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Feb 8, 2026 ETOP
OPPOSITION INSTITUTED NO. 999999
Feb 4, 2026 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Sep 5, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 12, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 12, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 6, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 1, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 1, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 1, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 1, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 30, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 30, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 30, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 13, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 13, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 20, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 20, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 20, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 11, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2025 NWOS
NEW APPLICATION ENTERED
Aug 26, 2024 NWAP